Ida Grundberg
Chief Tech/Sci/R&D Officer presso OLINK HOLDING AB
Profilo
Ida Grundberg is currently the Chief Scientific Officer at Olink Holding AB since 2019.
Prior to this, she worked at Olink Proteomics AB from 2011 to 2019 as the Head of Business Development, VP of Sales & Marketing.
She obtained a doctorate degree from the University of Uppsala and completed her undergraduate and graduate studies at Umea Universitet.
Posizioni attive di Ida Grundberg
Società | Posizione | Inizio |
---|---|---|
OLINK HOLDING AB | Chief Tech/Sci/R&D Officer | 01/09/2019 |
Precedenti posizioni note di Ida Grundberg
Società | Posizione | Fine |
---|---|---|
Olink Proteomics AB
Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden. | Sales & Marketing | 01/09/2019 |
Formazione di Ida Grundberg
University of Uppsala | Doctorate Degree |
Umea Universitet | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
OLINK HOLDING AB | Health Technology |
Aziende private | 1 |
---|---|
Olink Proteomics AB
Olink Proteomics AB Miscellaneous Commercial ServicesCommercial Services Olink Proteomics AB engages in developing and expanding its platform of high-multiplex immunoassay panels for protein biomarker discovery. Its product Olink panels for precision proteomics helps scientists with research decisions regarding biomarker analysis. Its multiplex immunoassay panels helps bring insights into disease processes, improves disease detection, and contributes to the understanding of biology. The company was founded by Ulf Landegren in 2004 and is headquartered in Uppsala, Sweden. | Commercial Services |
- Borsa valori
- Insiders
- Ida Grundberg